About Bolder BioPath
Bolder BioPath is a company based in Boulder (United States) founded in 2003 was acquired by Inotiv in April 2021. It operates as a Professional Services. The company has 47 employees as of December 31, 2022. Bolder BioPath offers products and services including In Vivo Models, In Vitro Services, and Pathology Services. Bolder BioPath operates in a competitive market with competitors including GenOway, TransCure bioServices, InVivo Biosystems, PsychoGenics and PharmaLegacy Laboratories, among others.
- Headquarter Boulder, United States
- Employees 47 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bolder Biopath, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bolder BioPath
Bolder BioPath offers a comprehensive portfolio of products and services, including In Vivo Models, In Vitro Services, and Pathology Services.
In vivo models are provided for preclinical research.
In vitro solutions are offered for decision-making support.
Pathology assessments are conducted for various disease states.
Funding Insights of Bolder BioPath
Detailed funding history for Bolder BioPath
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Bolder BioPath
Bolder BioPath has secured backing from 1 investor. Prominent investors backing the company include Inotiv Co.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Clinical development and regulatory services are provided by Inotiv.
|
Locked | Locked | Locked |
Investor details for Bolder BioPath
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bolder BioPath
Investment portfolio details for Bolder BioPath
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Bolder BioPath
Detailed financials for Bolder BioPath
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bolder Biopath Comparisons
Peer comparison for Bolder BioPath
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bolder BioPath
Bolder BioPath operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenOway, TransCure bioServices, InVivo Biosystems, PsychoGenics and PharmaLegacy Laboratories, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of transgenic rodent models and customized cell lines for preclinical development
|
|
| Locked | Locked | Locked |
Humanized mouse models are developed for preclinical immune drug studies.
|
|
| Locked | Locked | Locked |
Animal models are supplied for in-vivo analytical services.
|
|
| Locked | Locked | Locked |
Preclinical CRO services for CNS and orphan disorders are offered.
|
|
| Locked | Locked | Locked |
Preclinical CRO offering in vivo models and services for a wide range of therapeutic areas
|
|
| Locked | Locked | Locked |
Company offering primate models and services for preclinical drug discovery
|
Detailed competitors of Bolder BioPath
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bolder Biopath
Complete news archive for Bolder BioPath
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bolder BioPath
Bolder BioPath was founded in 2003.
Bolder BioPath is headquartered in Boulder, United States. It is registered at Boulder, Colorado, United States.
As of Dec 31, 2022, the latest employee count at Bolder BioPath is 47.
Bolder BioPath, an Inotiv company, is focused on contract pharmacology and pathology services, specializing in in vivo models for autoimmune and inflammation conditions such as Rheumatoid Arthritis and Inflammatory Bowel Disease. Services are provided across therapeutic areas including cardiovascular, neuroscience, and oncology. Preclinical data is generated to support drug development from discovery to INDNDA stages. Solutions encompass in vitro and ex vivo analyses, safety assessments, and toxicology studies. The company caters to pharmaceutical and biotech sectors with customized research models and consultative drug discovery programs.
Bolder BioPath's top competitors include GenOway, PsychoGenics and Alpha Genesis.
Bolder BioPath offers In Vivo Models, In Vitro Services, and Pathology Services.
Bolder BioPath has 1 investor. Key investors include Inotiv Co.